Position:home  

Fidelity Select Biotechnology Stock Price: 64.28 USD

Overview

The Fidelity Select Biotechnology Portfolio (ticker: FSELX) is a mutual fund that invests in biotechnology companies. The fund's objective is to provide long-term capital appreciation by investing primarily in common stocks of companies that are involved in the research, development, and/or marketing of biotechnology products.

Performance

FSELX has a long history of strong performance. Over the past 10 years, the fund has returned an average of 12.2% per year, compared to 9.8% for the S&P 500 Index. The fund's 10-year return is also higher than the average return of its peer group, which is 11.1%.

Risk

FSELX is a relatively high-risk investment. The fund invests in a concentrated portfolio of biotechnology companies, which means that it is more volatile than the overall stock market. The fund's beta, which is a measure of volatility, is 1.24. This means that the fund is 24% more volatile than the S&P 500 Index.

fidelity select biotechnology stock price

Investment Strategy

FSELX invests in a variety of biotechnology companies, including companies that are developing new drugs, medical devices, and diagnostic tests. The fund's portfolio is managed by a team of experienced investment professionals who have a deep understanding of the biotechnology industry.

The fund's investment strategy is based on several key factors, including:

  • The company's technology platform
  • The company's pipeline of products
  • The company's management team
  • The company's financial strength

The fund's managers believe that by investing in companies with strong technology platforms, pipelines, management teams, and financial strength, they can generate long-term capital appreciation for their investors.

Fees

FSELX has an expense ratio of 0.75%. This means that for every $1,000 invested in the fund, $7.50 will be used to pay for the fund's operating expenses. The fund's expense ratio is higher than the average expense ratio of its peer group, which is 0.65%.

Fidelity Select Biotechnology Stock Price: 64.28 USD

Tax Implications

FSELX is a mutual fund, which means that it is subject to capital gains taxes. When the fund sells a stock, the proceeds are distributed to shareholders, who are then responsible for paying taxes on the gains. The fund's distributions are classified as either qualified or non-qualified. Qualified distributions are taxed at the capital gains rate, while non-qualified distributions are taxed at the ordinary income rate.

Conclusion

FSELX is a high-risk, high-reward investment. The fund has a long history of strong performance, but it is important to remember that past performance is not a guarantee of future results. The fund's high expense ratio and tax implications should also be considered before investing.

Time:2024-12-28 07:07:57 UTC

invest   

TOP 10
Related Posts
Don't miss